These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 11230738
21. Effects of rapamycin, cyclosporin A, and dexamethasone on interleukin 5-induced eosinophil degranulation and prolonged survival. Meng Q, Ying S, Corrigan CJ, Wakelin M, Assoufi B, Moqbel R, Kay AB. Allergy; 1997 Nov; 52(11):1095-101. PubMed ID: 9404561 [Abstract] [Full Text] [Related]
22. Increased eosinophil infiltration and degranulation in colonic tissue from patients with collagenous colitis. Levy AM, Yamazaki K, Van Keulen VP, Burgart LJ, Sandborn WJ, Phillips SF, Kephart GM, Gleich GJ, Leiferman KM. Am J Gastroenterol; 2001 May; 96(5):1522-8. PubMed ID: 11374693 [Abstract] [Full Text] [Related]
23. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, Poelstra K, Haisma HJ, Jansen PL, Moshage H. Hepatology; 2004 Jun; 39(6):1563-73. PubMed ID: 15185297 [Abstract] [Full Text] [Related]
24. Effect of beta2-adrenergic agonists on eosinophil adhesion, superoxide anion generation, and degranulation. Noguchi T, Nakagome K, Kobayashi T, Ueda Y, Soma T, Nakamoto H, Nagata M. Allergol Int; 2015 Sep; 64 Suppl():S46-53. PubMed ID: 26344080 [Abstract] [Full Text] [Related]
25. Circulating eosinophils in asthma, allergic rhinitis, and atopic dermatitis lack morphological signs of degranulation. Malm-Erjefält M, Greiff L, Ankerst J, Andersson M, Wallengren J, Cardell LO, Rak S, Persson CG, Erjefält JS. Clin Exp Allergy; 2005 Oct; 35(10):1334-40. PubMed ID: 16238793 [Abstract] [Full Text] [Related]
26. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F, Metters KM, O'neill GP. J Allergy Clin Immunol; 2001 Dec; 108(6):982-8. PubMed ID: 11742277 [Abstract] [Full Text] [Related]
27. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level. Fujimoto M, Oka T, Murata T, Hori M, Ozaki H. Eur J Pharmacol; 2009 Jan 14; 602(2-3):432-8. PubMed ID: 19059394 [Abstract] [Full Text] [Related]
28. Interaction with secretory component stimulates effector functions of human eosinophils but not of neutrophils. Motegi Y, Kita H. J Immunol; 1998 Oct 15; 161(8):4340-6. PubMed ID: 9780211 [Abstract] [Full Text] [Related]
29. The eosinophil: the cell and its weapons, the cytokines, its locations. Kariyawasam HH, Robinson DS. Semin Respir Crit Care Med; 2006 Apr 15; 27(2):117-27. PubMed ID: 16612762 [Abstract] [Full Text] [Related]
30. Effect of taurohyodeoxycholic acid on biliary lipid secretion in man: preliminary report. Loria P, Bozzoli M, Angelico M, Bertolotti M, Carubbi F, Concari M, Baiocchi L, Nistri A, Della Guardia P, Romani M, Carulli N. Ital J Gastroenterol; 1996 Sep 15; 28(7):391-2. PubMed ID: 8937941 [Abstract] [Full Text] [Related]
31. The cytotoxicity of hydrophobic bile acids is ameliorated by more hydrophilic bile acids in intestinal cell lines IEC-6 and Caco-2. Araki Y, Andoh A, Bamba H, Yoshikawa K, Doi H, Komai Y, Higuchi A, Fujiyama Y. Oncol Rep; 2003 Sep 15; 10(6):1931-6. PubMed ID: 14534721 [Abstract] [Full Text] [Related]
32. [Degranulation of eosinophils by IgG antibody to Candida antigen]. Ikeda Y, Mita H, Kudo M, Hasegawa M, Akiyama K. Arerugi; 1999 May 15; 48(5):546-53. PubMed ID: 10390902 [Abstract] [Full Text] [Related]
33. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome. Simon HU, Plötz S, Simon D, Seitzer U, Braathen LR, Menz G, Straumann A, Dummer R, Levi-Schaffer F. Eur J Immunol; 2003 Apr 15; 33(4):834-9. PubMed ID: 12672048 [Abstract] [Full Text] [Related]
34. Effect of steroids on immunoglobulin-induced eosinophil degranulation. Kita H, Abu-Ghazaleh R, Sanderson CJ, Gleich GJ. J Allergy Clin Immunol; 1991 Jan 15; 87(1 Pt 1):70-7. PubMed ID: 1991924 [Abstract] [Full Text] [Related]
35. Effect of disodium cromoglycate on deuterium oxide-induced degranulation of human eosinophils in allergic asthmatic patients in vitro. Pałczyński C, Górski P, Grzegorczyk J. Arch Immunol Ther Exp (Warsz); 1989 Jan 15; 37(1-2):157-60. PubMed ID: 2559674 [Abstract] [Full Text] [Related]
36. Taurochenodeoxycholic Acid Inhibited AP-1 Activation via Stimulating Glucocorticoid Receptor. Li L, Liu C, Mao W, Tumen B, Li P. Molecules; 2019 Dec 10; 24(24):. PubMed ID: 31835494 [Abstract] [Full Text] [Related]
37. ATP drives eosinophil effector responses through P2 purinergic receptors. Kobayashi T, Soma T, Noguchi T, Nakagome K, Nakamoto H, Kita H, Nagata M. Allergol Int; 2015 Sep 10; 64 Suppl(0):S30-6. PubMed ID: 26344078 [Abstract] [Full Text] [Related]
38. Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. Inoue Y, Matsuwaki Y, Shin SH, Ponikau JU, Kita H. J Immunol; 2005 Oct 15; 175(8):5439-47. PubMed ID: 16210651 [Abstract] [Full Text] [Related]
39. Biological activities of ecalectin: a novel eosinophil-activating factor. Matsumoto R, Hirashima M, Kita H, Gleich GJ. J Immunol; 2002 Feb 15; 168(4):1961-7. PubMed ID: 11823532 [Abstract] [Full Text] [Related]
40. Human eosinophils in vitro. An ultrastructural morphology primer. Dvorak AM, Ishizaka T. Histol Histopathol; 1994 Apr 15; 9(2):339-74. PubMed ID: 8075495 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]